Skip to main content
Guilherme Fleury Perini on Muck Rack

Guilherme Fleury Perini

As seen in: ONCOLOGY journal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Guilherme Fleury

Contact Guilherme Fleury, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Guilherme Fleury Perini, MD, PhD

|
By Guilherme Fleury Perini
| ONCOLOGY journal Verified
Guilherme Fleury Perini, MD, PhD Articles by Guilherme Fleury Perini, MD, PhD Guilherme Perini, MD, PhD, explained the rationale behind the KEYFORM-008 trial, exploring how targeting LAG-3 can reverse checkpoint inhibitor resistance.
Open in Who Shared Issue with article?

Overcoming PD-1 Resistance in Relapsed/Refractory Hodgkin Lymphoma

|
By Guilherme Fleury Perini, Rachna T Shroff, James Harding Verified
| ONCOLOGY journal Verified
At the 2026 European Hematology Association (EHA) Congress, long-term data from the phase 2 KEYFORM-008 trial (NCT05508867) were presented by Guilherme Perini, MD, PhD, first author of the study and investigator at Instituto Américas and Einstein Hospital Israelita in São Paulo, Brazil, who shed light on a novel approach for managing classic Hodgkin lymphoma that has grown resistant to standard PD-1 blockade.
Open in Who Shared Issue with article?
See all 2 articles